Newborn Blood Spot Test (Heel Prick Test) | NHS

Why It Matters

Early detection of serious genetic conditions improves outcomes and reduces long‑term costs, while respecting parents’ right to choose screening for their newborn.

Key Takeaways

• Heel prick test performed at five days old.
• Screens for rare, serious inherited metabolic diseases in newborns.
• Parents can opt for individual or full screening panels.
• Positive results trigger rapid follow‑up diagnostic testing for the infant.
• Screening is recommended but remains a voluntary choice.

Summary

The video explains NHS’s newborn blood‑spot (heel‑prick) test, offered to babies like Thomas when they reach five days old. It outlines the procedure—collecting a few drops of heel blood—to screen for serious inherited conditions.

The test can detect rare metabolic disorders, sickle‑cell disease, cystic fibrosis and congenital hypothyroidism. Parents may choose individual screens or the full panel of inherited metabolic diseases, or decline entirely. Positive screens prompt swift additional investigations.

Katie’s story illustrates the process: after birth, a midwife presents the option, and families are directed to www.nhs.uk/blood-spot-test for guidance. The video notes that only a small number of infants require further testing, which is arranged promptly.

Early identification enables timely treatment, reducing morbidity and healthcare costs, while preserving parental autonomy. The program underscores the NHS’s preventive strategy and the importance of informed consent in neonatal care.

Original Description

This video shows the blood spot test that is offered after your baby has been born. Screening tests are always a choice. Find out which tests are right for you and your baby. For more information visit: https://www.nhs.uk/baby/newborn-screening/blood-spot-test/